Stelvio Therapeutics joins JLABS San Diego

September 26, 2017 marked the day Stelvio joined Johnson & Johnson Innovation JLABS in San Diego, California. This vibrant ecosystem is a catalyst for innovation with a capital efficient no strings attached business model. This enables Stelvio to focus on it's mission to deliver innovative medicines of value to patients and being a resident of JLABS provides exposure to key deal makers for R&D collaborations.


Stelvio presenting at Enzymes in Drug Discovery Summit on February 23, 2018 in San Diego

Alexey Terskikh, PhD, Chief Scientific Officer of Stelvio will be presenting in the track titled "Epigenetic Enzymes in Drug discovery" and in the session "Epigenetic Modification & Transcriptional Regulation." For more information, please visit the conference website:

Stelvio Oncology Presenting at Indie Bio's Demo Day on September 14, 2017

I'm very excited to be presenting Stelvio Oncology at Indie Bio's Demo Day on September 14, 2017. I'll be on stage presenting with eleven other great biotechnology startup companies! 

Please see event details here:


Stelvio Oncology featured in Popping the Bubbl

Great conversation with Pete Turner and Sandra Ponce de Leon bringing to light how we are discovering novel cancer therapeutics with our innovative technology.